Want to see AU:MPL full AI Analyst Report?
MPL Stock Chart & Stats
AU$5.12
AU$0.02(0.39%)
At close: 4:00 PM EDT
AU$5.12
AU$0.02(0.39%)
Day’s Range― - ―
52-Week RangeAU$4.06 - AU$5.31
Previous CloseN/A
Volume3.75M
Average Volume (3M)5.96M
Market Cap
AU$13.63B
Enterprise ValueAU$13.94K
Total Cash (Recent Filing)AU$570.40M
Total Debt (Recent Filing)AU$273.90M
Price to Earnings (P/E)20.7
Beta0.22
Next Earnings
Feb 24, 2027EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend Yield3.81%
Share Statistics
EPS (TTM)0.23
Shares Outstanding2,754,003,200
10 Day Avg. Volume5,399,409
30 Day Avg. Volume5,964,521
Financial Highlights & Ratios
PEG Ratio0.78
Price to Book (P/B)5.63
Price to Sales (P/S)1.47
P/FCF Ratio22.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$5.00Price Target Upside-2.34% Downside
Rating ConsensusHold
Number of Analyst Covering7
EPS Forecast (FY)0.25
Revenue Forecast (FY)AU$9.72B
Bulls Say, Bears Say
Bulls Say
Health Services Growth And DiversificationRapid growth in Medibank Health and the Better Medical acquisition broaden MPL beyond insurance underwriting. A larger primary-care platform can diversify earnings, deepen member engagement and create recurring healthcare growth opportunities.
Strong Capital PositionCapital materially above the target range provides resilience against claims or regulatory shocks and supports investment in health services. It also gives MPL flexibility to fund expansion and potentially raise Tier-2 debt without immediate balance-sheet strain.
High-quality Cash GenerationCash conversion close to reported earnings indicates that profitability is generally supported by realized cash flows rather than accounting effects. This strengthens MPL’s ability to fund dividends, investment and acquisitions through its operating model.
Bears Say
Claims And Cost Inflation PressurePersistent expense inflation and elevated extras claims can compress underwriting margins if premium increases lag costs. Although hospital utilization was lower, claims mix and healthcare cost pressure remain structural risks to earnings durability.
Competitive Mix And Switching PressureGreater switching and demand for lower-tier cover can weaken retention, reduce revenue per policy and limit pricing power. This may make sustainable premium growth harder even if policyholder numbers continue to rise.
Volatile Investment IncomeInvestment income supplements insurance earnings, so weaker returns create a recurring earnings headwind when rates or portfolio performance decline. This adds volatility to results and increases reliance on underwriting and health-services profitability.
Medibank Private News
MPL FAQ
What was Medibank Private Ltd.’s price range in the past 12 months?
Medibank Private Ltd. lowest share price was AU$4.06 and its highest was AU$5.31 in the past 12 months.
What is Medibank Private Ltd.’s market cap?
Medibank Private Ltd.’s market cap is AU$13.63B.
When is Medibank Private Ltd.’s upcoming earnings report date?
Medibank Private Ltd.’s upcoming earnings report date is Feb 24, 2027 which is in 182 days.
How were Medibank Private Ltd.’s earnings last quarter?
Medibank Private Ltd. released its earnings results on Aug 19, 2026. The company reported AU$0.123 earnings per share for the quarter, beating the consensus estimate of AU$0.121 by AU$0.002.
Is Medibank Private Ltd. overvalued?
According to Wall Street analysts Medibank Private Ltd.’s price is currently Overvalued.
Does Medibank Private Ltd. pay dividends?
Medibank Private Ltd. pays a Semiannually dividend of AU$0.109 which represents an annual dividend yield of 3.81%. See more information on Medibank Private Ltd. dividends here
What is Medibank Private Ltd.’s EPS estimate?
Medibank Private Ltd.’s EPS estimate is 0.12.
How many shares outstanding does Medibank Private Ltd. have?
Medibank Private Ltd. has 2,754,003,200 shares outstanding.
What happened to Medibank Private Ltd.’s price movement after its last earnings report?
Medibank Private Ltd. reported an EPS of AU$0.123 in its last earnings report, beating expectations of AU$0.121. Following the earnings report the stock price went down -6.362%.
Which hedge fund is a major shareholder of Medibank Private Ltd.?
Currently, no hedge funds are holding shares in AU:MPL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medibank Private Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$5.00 (-2.34% Downside)
AU$5.00 (-2.34% Downside)
News Sentiment
Very Bullish
Bullish news 89%
Bearish news 11%
Bearish news 11%
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.92%
12-Months-Change
Fundamentals
Return on Equity
3.81%
Trailing 12-Months
Asset Growth
6.90%
Trailing 12-Months
Company Description
Medibank Private Ltd.
Medibank Private Limited (MPL.AX) is an Australian firm offering private health insurance alongside a variety of health services. The company operates through two primary divisions. Its Health Insurance division provides a comprehensive suite of private health insurance policies, encompassing coverage for hospital treatments and supplementary benefits for services like dental, optical, and physiotherapy. This division also caters to international visitors and students with specific insurance products, all underwritten by the Medibank and ahm brands. The Medibank Health division delivers health management programs, in-home care solutions, and telehealth services, primarily serving governmental and corporate clients. Furthermore, this segment handles the distribution of travel, life, and pet insurance products. Established in 1976, Medibank Private Limited is headquartered in Docklands, Australia.
MPL Company Deck
MPL Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed positive operational momentum and strategic progress: group operating profit rose 6%, Medibank Health delivered strong double-digit revenue and profit growth, policyholder growth improved and the company completed a transformative primary care acquisition while maintaining a strong capital position and lifting the interim dividend. Headwinds exist—expense inflation, a revenue-mix shift toward lower-tier products, elevated claims dynamics in extras, negative hospital utilization (partly COVID-driven), lower investment income and competitive pressure from aggregators—but management presented mitigation plans, unchanged guidance ranges, and clear capacity to invest further in health businesses. Overall, the positives (earnings growth, Medibank Health acceleration, M&A scale, capital strength and customer engagement) outweigh the manageable near-term challenges.View all AU:MPL earnings summariesMPL Stock 12 Month Forecast
Average Price Target
AU$5.00
▼(-2.34% Downside)